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Abstract
Various molecular methods have been used for the rapid identification of mycobacterial species. In this survey, evaluation of antibiotic
resistance and PCR-restriction fragment length polymorphism analysis (PRA) of the hsp65 gene was carried out for identification of non-
tuberculosis mycobacteria (NTM) isolates from different clinical specimens. Forty-eight different mycobacterial isolates were selected and
followed by the conventional and PRA of hsp65 for species identification. The antibiotic susceptibility test was carried out according to
standard methods. A 439 bp PCR product of hsp65 in all selected isolates was amplified and digested with the BstEII and HaeIII restriction
enzymes. The restriction fragment length polymorphism (RFLP) patterns were analyzed for species identification. Using PRA for 48 myco-
bacterial selected isolates, including 15 M. tuberculosis, one M. bovis and all 32 isolates of NTM, revealed 11 different species among the
NTM isolates. The most frequent NTM isolates were M. kansasii, M. gordonae III, M. marinum, M. chelonae, M. scrofluaceum and M. gastri. In
most cases, the PRA results were perfectly in accordance with the classical biochemical method. Combination of resistance to rifampin and
isoniazid was present among M. kansasi, M. gordoniae III, M. scrofluaceum, M. chelonae, M. marinum, M. gastri, M. gordoniae II and M. trivale
isolates. A high incidence of co-resistance to six, five, four and three anti-TB drugs was observed in 18.5%, 9.1%, 6.6% and 11.7% of all
NTM isolates, respectively. Our results showed that PRA, in comparison with classical methods, is rapid and accurate enough for the iden-
tification of mycobacterial species from LJ medium. Additionally, we found that in Iran we have a highly diverse population of NTM isolates
among patients suspected of having TB.
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Introduction
The genus Mycobacterium comprises more than 70 species,
some of which are pathogenic to humans and animals and
some of which are saprophytes. The Mycobacterium tuberculo-
sis complex (MTBC) includes M. tuberculosis, M. bovis, M. mic-
roti, M. africanum and M. canetti. M. tuberculosis and M. bovis
are the most common isolates in human tuberculosis and
can be differentiated by biochemical tests, growth pheno-
types and several genetic markers. Because of the AIDS
pandemic, there has been a dramatic increase in the number
of diseases caused by the Mycobacterium tuberculosis complex
and non-tuberculosis mycobacteria (NTM) [1].
Identification of mycobacteria to species level is essential
and provides useful information on epidemiology and facili-
tates successful treatment of patients. Classical identification
of Mycobacteria based on cultural and biochemical tests is
tedious and time-consuming and sometimes fails to report a
correct identification. The variety of molecular techniques
such as PCR and other nucleic acid amplification methods are
widely used and overcome these disadvantages. Among these
different methods, PCR-restriction fragment length polymor-
phism analysis (PRA) is preferred because it offers an easy,
rapid and inexpensive method of identifying mycobacteria spe-
cies in a single experiment. Moreover, the technique has been
applied to several genes, for example 16S ribosomal DNA
(rDNA), hsp65, dnaJ, groES and rpoB genes. The hsp65 gene
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coding for a 65 KDa protein is present in all the species of
mycobacteria and contains epitopes that are unique as well as
common to various species of mycobacteria [1–5].
Our aim was to evaluate the PRA method for differentia-
tion of NTM isolates using the hsp65 gene PCR amplification.
We have applied PRA followed by computer analysis to both
reference and clinical isolates. Furthermore, to study the util-
ity of PRA in identification of different mycobacteria species,
we also characterized them by biochemical tests.
Material and Methods
Reference strains
The reference culture strains of M. tuberculosis (CRBIP7.11),
M. chelonae (CIP104535), M. kansasii (CRBIP7.98), M. scro-
fluaceum (CRBIP7.163) and M. fortuitum (CRBIP17.99) were
used as comparison controls in order to categorize the
mycobacteria patterns in species identification grouping with
the PRA method.
Mycobacterial strains
All the 4892 clinical samples, including sputum, synovial fluid,
urine, tissue biopsy and bronchial fluid, collected from
patients suspected of having tuberculosis, referred to the
Mycobacteriology Department of the Pasteur Institute of Iran
during January 2010 to May 2011, were investigated. Demo-
graphic and clinical details of each patient were collected
during sampling. Direct microscopic examination and pro-
cessing of cultures were carried out for presence of acid-fast
bacilli according to the standard guidelines [6,7] The stan-
dard strains were also included as controls.
Biochemical tests
Identification of mycobacteria to species level was based on
their growth rate, pigmentation and biochemical tests
according to the CDC guidelines [7].
Antimicrobial susceptibility test
Susceptibility testing was performed by the proportional
method using the critical concentrations of 40 lg/mL for
rifampin, 0.2 lg/mL for isoniazid, 4 lg/mL for streptomycin,
2 lg/mL for ethambutol and 100 lg/mL for ethionamide.
Interpretation of the results was performed according to the
CDC guidelines [7].
DNA extraction
Two or three loops of freshly grown mycobacterial cultures
from LJ medium were harvested and chromosomal DNA
was purified using a silica gel column system (High pure
DNA Extraction Kit, Roche Diagnostics, Manheim, Germany)
and kept at )20C until use.
PCR of hsp65
A set of primers including Tb11 (5¢ – CAACGATG
GTGTGTCCCAT) and Tb12 (5¢ – CTTGTCGAACCGCAT
ACCCT) were used. The PCR was carried out in a final vol-
ume of 25 lL, consisting of 5 lL of DNA, 200 lM of each of
the deoxynucleoside triphosphates (dNTPs), 25 pmol of each
primer, 1.5 mM MgCl2, 1.25 U Taq DNA polymerase and
2.5 lL of 10· PCR buffer. The reaction mixture was subjected
to initial denaturation at 94C for 5 min followed by 35 ampli-
fication cycles (60 s at 94C, 60 s at 60C and 60 s at 72C).
Final extension was carried out at 72C for 10 min (Model
22331 Thermocycler; Eppendorf, Hamburg, Germany) [8].
Amplification of the 439 bp product of the hsp65 gene was
detected by 1.5% agarose gel electrophoresis.
Restriction fragment length polymorphism
RFLP was carried out with the BstEII and HaeIII on all the
standard strains first and then applied to isolates. PCR prod-
uct (12.5 lL) was digested by 5 U of BstEII (Roche Diagnos-
tics) or HaeIII (Roche Diagnostics) for 2 h at 37C. The
digested products were loaded on 3% agarose gel electro-
phoresis at 100 V for 2 h [8]. To interpret the PRA profiles
generated by each species, a 50 bp ladder DNA size marker
(MBI Fermentans, Bois-Noir, Germany) was used. The frag-
ments were detected with ethidium bromide staining and UV
transilluminator. The species identification according to the
size of restriction fragments generated was estimated with
the help of GelcomparII version 4.0 (Applied Maths, Sint-Ma-
tens-Latem, Belgium) and using an algorithm of PRA patterns
of Telenti et al. [9] and Taylor et al. [10].
Results
According to the biochemical tests amongst studied isolates,
229 positive cultures were obtained, which included
183 M. tuberculosis, 14 M. bovis and 32 NTM strains. Accord-
ing to our patient’s questionnaire, 32 NTM isolated cases
included 17 (53.1%) men and 15 (46.9%) women. Signs of TB,
including coughing up sputum, weight loss, fatigue, fever and
chills, hemoptysis and night sweats, were observed in 48.2%,
37.5%, 37.5%, 25%, 18.7% and 15.6%, respectively. We had
five (15.6%) HIV cases among our studied population.
All M. tuberculosis isolates were non-pigmented, nitrate
positive, niacin positive, resistant to Thiophen-2-Carboxylic
Hydrazine (TCH), negative semi-quantitative (sq) catalase
and stability of catalase activity at 68C. Direct microscopic
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examination among M. tuberculosis culture-positive samples
was negative in 37.5%, whereas 62.5% were positive.
Twenty-seven (84.3%) of 32 NTM isolates had negative
results of direct microscopy smear. Susceptibilities were per-
formed on all studied isolates. Eight of ten (80%) M. kansasi
isolates, two of seven (27.8%) M. gordoniae III isolates and
the only M. trivale isolate were resistant to all six tested anti-
TB drugs (Fig. 1). A combination of resistance to rifampin
and isoniazid was present among M. kansasi, M. gordoniae III,
M. scrofluaceum, M. chelonae, M. marinum, M. gastri, M. gordo-
niae II and M. trivale isolates. A high incidence of co-resis-
tance to six, five, four and three anti-TB drugs was observed
in 18.5%, 9.1%, 6.6% and 11.7% of all NTM isolates, respec-
tively (Fig. 1).
A 439 bp PCR product among all 48 mycobacterial stud-
ied isolates was detectable (Fig. 2).
Having performed RFLP on the PCR product of hsp65 and
using the restriction profiles, the 48 selected clinical myco-
bacteria isolates were identified to species level. All M. tuber-
culosis clinical isolates were identified and produced a similar
pattern to M. bovis and M. tuberculosis H37Rv strains. Among
complex isolates of mycobacterium tuberculosis, during the
BstEII digestion experiment, three fragments of 245, 120 and
80 bp were detected (Fig. 2),while during HaeIII digestion,
three different fragments, including 160, 140 and 70 bp, were
observed (Fig. 3). Restriction fragments shorter than 60 bp
were not analysed for increase in the accuracy of strain
detection.
Among all different NTM isolates, the most frequent spe-
cies were M. kansasii, M. gordonae III, M. marinum, M. chelo-
nae, M. scrofluaceum and M. gastri, in ten, seven, three, three,
three and two isolates, respectively (Table 1).
FIG. 1. Dendrogram generated by the Gel-
compar II software (Applied Maths) showing
the relationship of mycobacterial isolates. The
analysis of the bands generated was performed
using the Dice coefficient and unweighted pair
group method with arithmetic averages (UP-
GMA). TB, TB complex; A, atypical mycobac-
teria; Sp, sputum; S.F, synovial fluid; BAL,
bronchio alveolar lavage; U, urine; N, negative;
P, positive; R, resistant; S, sensitive; ETH, ethi-
onamid; K, kanamycin; EMB, ethambutol; Rif,
rifampin; St, streptomycin; INH, isoniazide.
*HIV positive.
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The PRA results were perfectly in accordance with those
of the classical biochemical method, except for one isolate,
which was identified as M. flavescens II using the PRA method
but reported as M. tuberculosis with biochemical tests
(Table 2). We did not have any unknown NTM mycobacteria
in our study.
Discussion
This study aims to give a broader view of the identification
of NTM infections in humans using the PRA method, which
is more accurate and rapid. Identification of species among
mycobacteria is valuable because it provides useful informa-
tion regarding patient management and proper treatment
[11–13]. Outbreaks of NTM infections related to contami-
nated instruments in hospitals have been described all over
the world. NTM can easily affect the skin and in immune-
suppressed patients spread towards the pulmonary or lymph
node system or even reproduce a systematic illness [14–16].
NTM disease patterns and epidemiology have changed since
the 1980s and gradually emerged in unrecognized popula-
tions [17]. NTM are being increasingly recognized as signifi-
cant human pathogens and the prevalence of disease caused
by NTM is rising and species diversifying because of AIDS
and other immune deficient conditions [11,16]. The infec-
tions caused by opportunistic mycobacteria entities are dis-
tinct from infections caused by M. tuberculosis. Environmental
mycobacteria exhibit great variation in growth rates, colony
morphologies and virulence and antibiotic sensitivities [17].
There is no general agreement about the treatment of
patients with NTM infections [13,16,18]. In spite of high spe-
cies diversity we found similar patterns of drug resistance
between different NTM species.
FIG. 2. Lane 1: 439 bp PCR product of hsp65 gene. Lanes 2, 3, 5
and 6: RFLP patterns of TB complex strains with BstEII. Lanes 4,7
and 8: RFLP patterns of NTM strain with BstEII. Lane 9: molecular
weight marker.
FIG. 3. Lanes 1 and 2: RFLP patterns of M. tuberculosis strains with
HaeIII. Lane 3: RFLP patterns of M. bovis strain. Lane 4: RFLP pat-
terns of NTM strain. Lane 5: molecular weight marker.
TABLE 1. Summary of PRA results for the NTM isolates
PRA
patterns
Bands with
BstEII
Bands with
HaeIII
No. of
isolates (%)
M. kansasii I 245/220 140/105/80 9 (28.2)
M. gordonae III 245/120/100 140/120 7 (21.9)
M. marinum 245/220 160/115/80 3 (9.4)
M. chelonae II 325/120 140/65/60 3 (9.4)
M. scrofluaceum 245/220 155/135/95 3 (9.4)
M. gastri 245/110/80 140/105/70 2 (6.3)
M. gordonae II 245/120/80 235/115 1 (3.1)
M. gordonae IV 325/120 140/115/70 or 60 1 (3.1)
M. trivale – 180/140 1 (3.1)
M. simiae I 245/220 200/135 1 (3.1)
M. flavescens II 245/220 150/100 1 (3.1)
TABLE 2. Differentiation of mycobacterial strains into spe-
cies level with the PRA and classical biochemical methods
Species No. of isolates
Classical biochemical method
M. tuberculosis 15
M. bovis 1
Non-tuberculosis mycobacteria 32
Total 48
hsp65 RFLP
M. tuberculosis complex 15
Non-tuberculosis mycobacteria 33
Total 48
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The in vitro drug sensitivity tests are empirically applied to
treat NTM infections. During these infections the failure of
chemotherapy is often attributed to drug resistance. Variable
results if in vitro drug sensitivity tests against NTM, causes
the long duration of chemotherapy in NTM diseases [16,17].
It is therefore important to develop methods that pro-
vide precise and rapid results for identification of NTM
from complex TB strains. These methods should be cost-
effective and could be used in a wide variety of laborato-
ries around world. Several molecular techniques have been
used for identification of mycobacterial species, and among
these methods PRA has advantages due to its ease and
rapidity. This method targets conserved genes among all
mycobacteria and shows sufficient sequence variation to
differentiate them to the species level, such as hsp65
[2,3,8,11,14].
As species differentiation by the HaeIII restriction enzyme
needs to detect polymorphisms of fragments smaller than
100 bp, this method requires special software analysis for
interpretation of RFLP patterns and reduction of the gel to
gel variations. We analysed the RFLP patterns with the aid of
GelcomparII software because the virtual interpretations
would be difficult due to the fact that one of the restricted
bands differed by only 5–10 bp.
During the present study, out of the total number of iso-
lates, 11 different mycobacterial species other than tubercu-
losis were identified. According to our results, NTM
infections in Iran could be caused by 11 species, including
M. simiae, M. gordonae II, M. trivale, M. gordonae IV, M. mari-
num, M. scrofluaceum, M. kansasii, M. chelonae, M. gordonae III,
M. gastri and M. flavescens II, using the two restriction
enzymes, Hae III and BstEII. These results indicate a high vari-
ation of species among NTM in clinical isolates in Iran. Three
important factors that could increase the clinical cases of
environmental mycobacteria are defects in disinfection of
drinking water, disinfection in medical and industrial settings
and an increasing percentage of our population with predis-
posing conditions, such as age and immunosuppressive regi-
mens [14].
On the other hand, increases in the frequency of NTM infec-
tions throughout the world may have been due to a higher
awareness of NTM disease among clinicians, which resulted in
more requests for species identification of NTM infections.
Differentiations between four species of M. chelonae,
M. fortuitum, M. kansasii and M. scrofluaceum, which are the
most clinically important NTM, were possible using this
method. PRA is useful for identifying clinical isolates giving
mixed biochemical results, a situation that would require
choosing between two or three closely related species. Dur-
ing the present study two isolates that were biochemically
identified as M. tuberculosis were detected as NTM with the
PRA method. These strains were contaminated with
M. tuberculosis colonies. We used separate rooms for DNA
extraction, PCR mix preparation and amplification to prevent
PCR-related contamination and false identification. The
inability of hsp65-RFLP to differentiate between M. tuberculo-
sis and M. bovis depends on high DNA homology between
these species.
M. kansasii had the most frequent cluster with ten isolates.
In 1994 in Iran, among 82 NTM isolates, the percentages of
atypical mycobacterial strains were M. fortuitum 26.8%,
M. gastri 23.1% and M. terrae complex 18.3% [19]. According
to the Shojaii et al. [11] report in 2011 in Iran, the three
most prevalent NTM isolates were M. fortuitum, M. kansasii
and M. gordoniae.
The different reports of mycobacterial species might be
related to different geographical conditions and study popula-
tions [20].
According to statistical reports, the isolation of NTM
increased significantly from 248 (19%) in 2003 to 407 (30%)
in 2006, with the top five frequently isolated strains being
the M. chelonae group, the M. avium-M. intracellulare com-
plex, M. gordonae, the M. fortuitum group and M. kansasii
[3].
NTM are distinguished from the members of the M. tuber-
culosis complex by the fact that they are not obligate patho-
gens. In endemic NTM regions such as Iran the PRA method
has valuable potential because of its precise clinical results,
which aid in patient management and prevention strategies.
In developing countries with endemic TB such as Iran,
because of the inadequacy of laboratory services, NTM infec-
tions have developed.
In spite of the recent profusion of new mycobacterial spe-
cies, recent reports document that 30% of mycobacterial iso-
lates from water, soil, air and patients do not belong to any
of the identified species and there are a number of species
yet to be discovered [12].
In summary, we found an increasing incidence and species
diversity of NTM isolates from patients at our centre. The
RFLP analysis of the 439 bp PCR product of the hsp65 gene
after BstEII and HaeIII digestions is effective enough for dif-
ferentiating mycobacteria at the species level. During the
present study PRA was used on culture-positive cases and it
is suggested that it should be used directly for clinical
samples.
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